Gossamer Bio (GOSS) Profit After Tax (2018 - 2026)

Gossamer Bio's Profit After Tax history runs 9 years deep, the most recent figure standing at -$46.7 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 27.37% year-over-year to -$46.7 million; the TTM figure through Mar 2026 stood at -$140.1 million (down 246.7% YoY), while the FY2025 annual figure was -$170.4 million, down 11170.18% from the prior year.
• Profit After Tax for Q1 2026 stood at -$46.7 million, down from -$40.9 million in the prior quarter.
• The five-year high for Profit After Tax was $26.9 million in Q4 2024, with the low at -$57.8 million in Q1 2022.
• The 5-year median for Profit After Tax is -$30.8 million (2024), against an average of -$21.7 million.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax plunged 435772.73% in 2023, then surged 156.17% in 2024.
• Gossamer Bio's Profit After Tax stood at $11000.0 in 2022, then slumped by 435772.73% to -$47.9 million in 2023, then soared by 156.17% to $26.9 million in 2024, then slumped by 252.09% to -$40.9 million in 2025, then retreated by 13.98% to -$46.7 million in 2026.
• Business Quant data shows GOSS's Profit After Tax at -$46.7 million in Q1 2026, -$40.9 million in Q4 2025, and -$48.2 million in Q3 2025.